0001572426-25-000005.txt : 20250711
0001572426-25-000005.hdr.sgml : 20250711
20250711162354
ACCESSION NUMBER: 0001572426-25-000005
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20250711
DATE AS OF CHANGE: 20250711
EFFECTIVENESS DATE: 20250711
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cecelia Health Holdings, Inc.
CENTRAL INDEX KEY: 0001820570
ORGANIZATION NAME:
EIN: 851924044
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-551507
FILM NUMBER: 251119260
BUSINESS ADDRESS:
STREET 1: 355 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 866-411-0254
MAIL ADDRESS:
STREET 1: 355 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10017
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001820570
Cecelia Health Holdings, Inc.
355 LEXINGTON AVENUE
NEW YORK
NY
NEW YORK
10017
866-411-0254
DELAWARE
None
None
Corporation
true
Mark
Clermont
c/o 750 Lexington Avenue, 9th Floor
New York
NY
NEW YORK
10022
Executive Officer
Director
Eric
Edidin
c/o 750 Lexington Avenue, 9th Floor
New York
NY
NEW YORK
10022
Director
Matthew
Klinger
c/o 750 Lexington Avenue, 9th Floor
New York
NY
NEW YORK
10022
Director
Richard
Barasch
c/o 750 Lexington Avenue, 9th Floor
New York
NY
NEW YORK
10022
Director
Cody
Nystrom
c/o 750 Lexington Avenue, 9th Floor
New York
NY
NEW YORK
10022
Director
Saul
Richter
c/o 750 Lexington Avenue, 9th Floor
New York
NY
NEW YORK
10022
Director
Charles
Flicker
c/o 750 Lexington Avenue, 9th Floor
New York
NY
NEW YORK
10022
Director
David
Lombardi
c/o 750 Lexington Avenue, 9th Floor
New York
NY
NEW YORK
10022
Executive Officer
Other Health Care
Decline to Disclose
- 06b
true
0001572426-25-000004
2025-06-26
false
true
true
false
0
19145586
16145587
2999999
Total Offering Amount and Total Amount Sold includes previously issued convertible securities which converted in financing round.
false
39
0
0
0
false
Cecelia Health Holdings, Inc.
/s/ Mark Clermont
Mark Clermont
Chief Executive Officer
2025-07-10